直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

PTAB and Discovery: An Insider’s Perspective

October 16, 2014

Authored and Edited by Anthony A. Hartmann

Recently, APJs Bonilla and Snedden authored a post on the USPTO AIA Blog entitled “Routine and Additional Discovery in AIA Trial Proceedings: What is the Difference?” Their post provides some meaningful insight into how the PTAB approaches routine and additional discovery and cites numerous decisions that may be useful to practitioners.

The APJs explain that “routine discovery” under Rule 42.51(b)(1)(i) has its limitations. While exhibits cited in a paper or testimony must be produced, no requirement exists for a party to create or provide materials that were not cited. Nor are parties required to produce materials that a party or witness considered in preparing the paper or the testimony.

The APJs note that “routine discovery” under Rule 42.51(b)(1)(ii) requires a party relying on a witness’s testimony by declaration or affidavit to make that witness available for cross-examination. “Normally, the burden and expense of producing a witness for cross-examination falls on the party presenting the witness.”

The APJs also address “routine discovery” under Rule 42.51(b)(1)(iii), which requires production of relevant information inconsistent with a position advanced by a party. They explain that the Rule is “narrowly directed” to information known by the party to be inconsistent with a position it has advanced and does not provide for broad discovery whereby the requesting party hopes to discover inconsistent information.

Regarding “additional discovery,” the APJs state that the “interest of justice” standard applied in IPRs is viewed as a “slightly higher” standard than the “good cause” standard for PGRs, including CBMs, reflecting “the more limited scope of issues raised in IPR petitions.”

The APJs discuss the five factors outlined in Paper 26 of Garmin Int’l, Inc. v. Cuozzo Speed Tech. LLC (IPR2012-00001) for evaluating whether additional discovery in an IPR is “necessary in the interest of justice” and cite a variety of decisions applying the Garmin factors. Though most of the cited decisions have not been deemed representative orders or decisions by the PTAB, they highlight the kinds of “additional discovery” that may be available. For example, the APJs cite Paper 66 from Apple Inc. v. Achates Reference Publ’g, Inc. (IPR2013-00080), granting discovery of emails between experts that were relied upon as a basis for their opinions.

Posts like the one authored by APJs Bonilla and Snedden provide practitioners an inside perspective on PTAB operations and are a welcome addition to the USPTO’s AIA Blog.

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Contacts

Anthony A. Hartmann
Of Counsel
Washington, DC
+1 202 408 4275
Email

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP